Mr. Speirs is a litigation shareholder in Parsons’ Salt Lake City office. His background in electrical engineering and decades of experience as an intellectual property litigator, trial lawyer, and appellate lawyer provide him with the skills and perspective to handle lawsuits and appeals involving virtually any technology.

Capabilities

Biography

Kevin Speirs is a shareholder in Parsons Behle & Latimer’s Litigation practice group. His practice focuses on intellectual property litigation, with an emphasis on patent infringement litigation and on antitrust matters. Mr. Speirs has handled patent infringement, trade secret, and other intellectual property litigation in many states. He has handled patent infringement matters covering a wide range of technologies, including biomedical and surgical devices, explosives and detonators, computer software, computer and electrical devices, oil and gas production devices and processes, microscopes and optics, nucleic acid and microbiological products and processes, wastewater treatment equipment, amino acid chelates, and many different types of mechanical devices, among others. His background in electrical engineering and years of experience as a litigator and trial lawyer provide him with the skills and perspective to handle lawsuits involving virtually any technology.

Additionally, Mr. Speirs has extensive appellate experience. He has handled over 20 appeals in the United States Court of Appeals for the Federal Circuit.

Mr. Speirs is a member of the Utah State Bar and its Intellectual Property Section. He is also a member of the American Bar Association and its Committee on Intellectual Properties Litigation.

Experience

Celsis In Vitro, Inc. v. CellzDirect, Inc., et al. (N.D. Ill. 2010 – Present), 995 F. Supp.2d 855 (N.D. Ill. 2011), 21 F. Supp.2d 960 (N.D. Ill. 2014), 83 F. Supp.3d 774 (N.D. Ill. 2015), 94 F. Supp.3d 940 (N.D. Ill. 2015), and 827 F.3d 1041 (Fed. Cir. 2016):


Celsis In Vitro, Inc. v. CellzDirect, Inc., et al.
(N.D. Ill. 2010-2015), 995 F. Supp.2d 855 (2011), affirmed, No. 2011-1337, Slip op. (Fed. Cir. 2011); 664 F.2d 922 (Fed. Cir. 2012); 21 F. Supp.2d 960 (2014), 83 F. Supp.3d 774 (2015), and 94 F. Supp.3d 940 (2015)

Represented defendants CellzDirect and Invitrogen (now Life Technologies) in a patent infringement action relating to method of preparing frozen hepatocytes. Successfully defeated a motion for preliminary injunction. Denial of injunction upheld on appeal. The case is pending.

Aleksandr L. Yufa v. Hach Ultra Analytics, Inc., 2014 WL 2450749 (D. Or. 2011-2015), affirmed, No. 2015-1626, Slip op. (Fed. Cir. 2015)

In re BRCA-1 and BRCA-2-Based Hereditary Cancer Test Patent Litigation (a/k/a University of Utah Research Foundation, et al. v. Ambry Genetics Corp.)


In re BRCA-1 and BRCA-2-Based Hereditary Cancer Test Patent Litigation (a/k/a University of Utah Research Foundation, et al. v. Ambry Genetics Corp.), (D. Utah 2014-2015), 3 F. Supp.3d 1213 (D. Utah 2014), 999 F. Supp. 2d 1377 (Judicial Panel on Multidistrict Litigation 2014), 774 F.3d 755 (Fed. Cir. 2014)

Accomplishments

Academic

University of Utah, S.J. Quinney College of Law (J.D. 1988)

Utah Law Review, Associate Editor, 1987-88

“The Seventh Circuit Shoots for Multiple Transfer of Cases,” Utah Law Review, February 1988

University of Utah (B.S. Electrical Engineering, 1985)

Cum Laude

Professional

Recognized in Chambers USA, 2008-present

Recognized in The Best Lawyers in America, 2008-present; Salt Lake City Lawyer of the Year, Patent Law, 2022; Salt Lake City Lawyer of the Year, Copyright Law, 2024

Mountain States SuperLawyers, Intellectual Property Litigation

Associations

Professional

American Bar Association, Intellectual Properties Litigation Committee

Member

(1989 - Present)

Utah State Bar, Intellectual Property Section

Member

(1989 - Present)

Insights

Credentials

Licensed

Utah
U.S. Court of Appeals, Federal Circuit
U.S. Patent & Trademark Office

Education

University of Utah, S.J. Quinney College of Law